Table 5.
Time-Updated HIV-1 RNA Viral Load, CD4 Cell Count, and the Risk of Heart Failure (HF) Type Among Human Immunodeficiency Virus (HIV)–Infected Veteransa
| Variable | Total HF | HFpEF≥50% | Borderline HFpEF 40%-49% | HFrEF | EF Missing |
|---|---|---|---|---|---|
| CD4 cells/mm3 | |||||
| ≥500 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| 200–499 | 1.26 (1.07–1.49) | 1.28 (0.97–1.72) | 0.67 (0.17–2.63) | 1.23 (0.95–1.60) | 1.98 (1.22–3.20) |
| <200 | 2.09 (1.71–2.55) | 1.87 (1.28–2.73) | 2.10 (1.30–3.39) | 1.87 (1.36–2.57) | 3.37 (1.95–5.84) |
| HIV-1 RNA viral load copies/mL | |||||
| <500 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| ≥500 | 1.31 (1.12–1.53) | 1.07 (0.80–1.43) | 1.26 (0.84–1.89) | 1.63 (1.28–2.08) | 1.18 (0.79–1.75) |
Abbreviations: EF, ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
Models are simultaneously adjusted for HIV-1 RNA viral load, CD4 cell count, age, race/ethnicity, hypertension, lipid levels, low-density lipoprotein and high-density lipoprotein cholesterol levels, triglyceride levels, smoking status, hydroxymethylglutaryl coenzyme A reductase inhibitor use, hepatitis C virus infection, renal disease, body mass index, substance use, atrial fibrillation, major depression, and baseline antiretroviral therapy regimen.